<DOC>
	<DOCNO>NCT00300287</DOCNO>
	<brief_summary>This study conduct United States . Key long-term clinical study show people type 2 diabetes try achieve overall blood glucose level close normal possible . The purpose study gather data long-term safety effectiveness vildagliptin , unapproved drug , compare placebo lower overall blood glucose level people type 2 diabetes previously treat drug therapy lower blood sugar whose blood glucose level close normal .</brief_summary>
	<brief_title>A 56-Week Extension Clinical Study Assess Efficacy Safety Vildagliptin Compared Placebo Drug Naive Patients With Type 2 Diabetes Mild Hyperglycemia</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Hyperglycemia</mesh_term>
	<mesh_term>Vildagliptin</mesh_term>
	<criteria>Completion study CLAF237A2307 within 4 week enter extension Written inform consent Ability comply study requirement Blood glucose criterion must meet Premature discontinuation study CLAF237A2307</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2007</verification_date>
	<keyword>Type 2 diabetes</keyword>
	<keyword>Vildagliptin</keyword>
</DOC>